IMMUNE-MEDIATED CHOLESTASIS

Clinical trials for IMMUNE-MEDIATED CHOLESTASIS explained in plain language.

Never miss a new study

Get alerted when new IMMUNE-MEDIATED CHOLESTASIS trials appear

Sign up with your email to follow new studies for IMMUNE-MEDIATED CHOLESTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for cancer patients: gentler liver treatment tested

Disease control Not yet recruiting

This study aims to find a better way to treat severe liver inflammation that can occur as a side effect of powerful cancer immunotherapies. It will compare a standard steroid treatment against a different drug called ursodeoxycholic acid (UDCA), which may have fewer side effects.…

Matched conditions: IMMUNE-MEDIATED CHOLESTASIS

Phase: PHASE2 • Sponsor: University Hospital, Montpellier • Aim: Disease control

Last updated Mar 11, 2026 14:52 UTC

IMMUNE-MEDIATED CHOLESTASIS

Get alerted when new IMMUNE-MEDIATED CHOLESTASIS trials appear

New hope for cancer patients: gentler liver treatment tested